vs
Side-by-side financial comparison of Li Bang International Corp Inc. (LBGJ) and Scilex Holding Co (SCLX). Click either name above to swap in a different company.
Scilex Holding Co is the larger business by last-quarter revenue ($4.8M vs $4.7M, roughly 1.0× Li Bang International Corp Inc.). Li Bang International Corp Inc. runs the higher net margin — -23.9% vs -961.9%, a 938.1% gap on every dollar of revenue.
Li & Fung Limited is a Hong Kong–based supply chain management company. Established in 1906, the company became publicly traded in 1973 and has since played a significant role in manufacturing apparel, toys, and various consumer goods for major North American and European retailers. Significant growth occurred after its public listing, reaching a peak market capitalization in 2011, but the rise of platforms like Alibaba and Amazon, which directly connect manufacturers with consumers, created ...
Scilex Holding Co is a commercial-stage biopharmaceutical firm focused on developing and commercializing innovative non-opioid pain management therapies for acute and chronic pain segments. It primarily serves the US market, offering prescription and over-the-counter pain relief solutions for patients and healthcare providers.
LBGJ vs SCLX — Head-to-Head
Income Statement — Q4 FY2024 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $4.7M | $4.8M |
| Net Profit | $-1.1M | $-46.1M |
| Gross Margin | 17.8% | 45.5% |
| Operating Margin | -25.1% | -2317.8% |
| Net Margin | -23.9% | -961.9% |
| Revenue YoY | — | -67.8% |
| Net Profit YoY | — | -613.7% |
| EPS (diluted) | $-0.06 | $-4.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $4.8M | ||
| Q3 25 | — | $10.6M | ||
| Q2 25 | — | $9.9M | ||
| Q1 25 | — | $5.0M | ||
| Q4 24 | $4.7M | $14.9M | ||
| Q3 24 | — | $14.4M | ||
| Q2 24 | — | $16.4M | ||
| Q1 24 | — | $10.9M |
| Q4 25 | — | $-46.1M | ||
| Q3 25 | — | $-257.8M | ||
| Q2 25 | — | $-44.0M | ||
| Q1 25 | — | $-26.1M | ||
| Q4 24 | $-1.1M | $-6.5M | ||
| Q3 24 | — | $-4.4M | ||
| Q2 24 | — | $-37.6M | ||
| Q1 24 | — | $-24.4M |
| Q4 25 | — | 45.5% | ||
| Q3 25 | — | 68.5% | ||
| Q2 25 | — | 66.9% | ||
| Q1 25 | — | 72.3% | ||
| Q4 24 | 17.8% | 68.5% | ||
| Q3 24 | — | 73.9% | ||
| Q2 24 | — | 73.2% | ||
| Q1 24 | — | 64.7% |
| Q4 25 | — | -2317.8% | ||
| Q3 25 | — | -1766.2% | ||
| Q2 25 | — | -207.2% | ||
| Q1 25 | — | -557.5% | ||
| Q4 24 | -25.1% | -190.5% | ||
| Q3 24 | — | -138.0% | ||
| Q2 24 | — | -95.4% | ||
| Q1 24 | — | -179.0% |
| Q4 25 | — | -961.9% | ||
| Q3 25 | — | -2441.5% | ||
| Q2 25 | — | -445.1% | ||
| Q1 25 | — | -521.2% | ||
| Q4 24 | -23.9% | -43.4% | ||
| Q3 24 | — | -30.4% | ||
| Q2 24 | — | -229.6% | ||
| Q1 24 | — | -224.0% |
| Q4 25 | — | $-4.63 | ||
| Q3 25 | — | $-22.17 | ||
| Q2 25 | — | $-7.42 | ||
| Q1 25 | — | $-2.26 | ||
| Q4 24 | $-0.06 | $8.53 | ||
| Q3 24 | — | $-0.58 | ||
| Q2 24 | — | $-7.67 | ||
| Q1 24 | — | $-8.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $5.0M |
| Total DebtLower is stronger | $10.2M | — |
| Stockholders' EquityBook value | $7.8M | $-207.8M |
| Total Assets | $28.8M | $365.0M |
| Debt / EquityLower = less leverage | 1.31× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $5.0M | ||
| Q3 25 | — | $878.0K | ||
| Q2 25 | — | $4.1M | ||
| Q1 25 | — | $5.8M | ||
| Q4 24 | — | $3.3M | ||
| Q3 24 | — | $77.0K | ||
| Q2 24 | — | $6.9M | ||
| Q1 24 | — | $1.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $10.2M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $-207.8M | ||
| Q3 25 | — | $-176.9M | ||
| Q2 25 | — | $-249.0M | ||
| Q1 25 | — | $-211.5M | ||
| Q4 24 | $7.8M | $-192.6M | ||
| Q3 24 | — | $-211.3M | ||
| Q2 24 | — | $-214.7M | ||
| Q1 24 | — | $-189.8M |
| Q4 25 | — | $365.0M | ||
| Q3 25 | — | $275.9M | ||
| Q2 25 | — | $83.8M | ||
| Q1 25 | — | $79.0M | ||
| Q4 24 | $28.8M | $93.0M | ||
| Q3 24 | — | $100.4M | ||
| Q2 24 | — | $104.5M | ||
| Q1 24 | — | $91.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.31× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $258.4K | $-17.5M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-17.5M | ||
| Q3 25 | — | $8.2M | ||
| Q2 25 | — | $7.0M | ||
| Q1 25 | — | $6.0M | ||
| Q4 24 | $258.4K | $2.5M | ||
| Q3 24 | — | $5.1M | ||
| Q2 24 | — | $2.3M | ||
| Q1 24 | — | $9.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
